View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
May 19, 2022

Medical Devices industry M&A deals total $1.4bn globally in April 2022

By Carmen

Total Medical devices industry M&A deals worth $1.4bn were announced globally in April 2022, led by Wallaby Medical’s $541.63m acquisition of Phenox, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 266.2% over the previous month of $390.55m and a drop of 81.4% when compared with the last 12-month average, which stood at $7.68bn.

Comparing M&A deals value in different regions of the globe, Europe held the top position, with total announced deals in the period worth $883.29m. At the country level, the Germany topped the list in terms of deal value at $541.63m.

In terms of volumes, North America emerged as the top region for Medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in April 2022 was the US with 16 deals, followed by the Germany with four and China with two.

In 2022, as of April, Medical devices M&A deals worth $8.59bn were announced globally, marking an increase of 72.6% year on year.

Medical devices industry M&A deals in April 2022: Top deals

The top five M&A deals accounted for 77.9% of the overall value during April 2022.

The combined value of the top five Medical devices M&A deals stood at $1.12bn, against the overall value of $1.4bn recorded for the month.

The top five Medical devices industry M&A deals of April 2022 tracked by GlobalData were:

1) Wallaby Medical $541.63m acquisition deal with Phenox

2) The $170m acquisition of Inform Diagnostics by Fulgent Genetics

3) Integer $141.73m acquisition deal with Aran Biomedical

4) The $140m acquisition of AltheaDx by Castle Biosciences

5) Cochlear $122.03m acquisition deal with Oticon Medical

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network